Elite Laboratories Inc.

FDA Regulatory Profile

Elite Laboratories Inc. has 1 FDA recall, 10 inspections, 0 510(k) clearances and 1 compliance action on record.

Latest recall
D-0107-2018 · Class III · Nov 13, 2017
Latest inspection
Aug 1, 2025 · VAI

Reviewing Elite Laboratories Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Elite Laboratories Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls1Nov 4, 2026 (checked Nov 8, 2026, unchanged)File dated Nov 3, 2026Current
510(k) clearances0Nov 8, 2026File dated Nov 2, 2026Current
Inspections10Nov 10, 2026Newest record Nov 5, 2026Current
Compliance actions1Nov 2, 2026Newest record Oct 29, 2026Current

Recent Recalls

NumberClassProductDate
D-0107-2018Class IIIIsradapine Capsules USP 2.5 mg, 100-count bottles, Rx only, Manufactured by: Elite Laboratories…Nov 13, 2017

Recent FDA Inspections

DateSiteProductClassificationFEI
Aug 1, 2025Northvale, NJDrugsVoluntary Action Indicated (VAI)3002644678
Mar 13, 2020Northvale, NJDrugsVoluntary Action Indicated (VAI)3002644678
Jan 21, 2020Northvale, NJDrugsNo Action Indicated (NAI)3002644678
Feb 2, 2018Northvale, NJDrugsNo Action Indicated (NAI)3002644678
Dec 4, 2017Northvale, NJDrugsNo Action Indicated (NAI)3002644678
Apr 24, 2017Northvale, NJDrugsVoluntary Action Indicated (VAI)3002644678
Feb 2, 2016Northvale, NJDrugsOfficial Action Indicated (OAI)3002644678
Jun 3, 2014Northvale, NJDrugsVoluntary Action Indicated (VAI)3002644678
Aug 14, 2012Northvale, NJDrugsVoluntary Action Indicated (VAI)3002644678
Apr 28, 2011Northvale, NJDrugsVoluntary Action Indicated (VAI)3002644678

NAI means no objectionable conditions or practices were found during the inspection. VAI means objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action. OAI means regulatory and/or administrative actions are recommended.

FDA-Inspected Facilities

FacilityLocationInspectionsLatest
FEI 3002644678Northvale, NJ10Aug 1, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.